DOC Q LACE  - docusate sodium liquid 
Qualitest Pharmaceuticals

----------

Doc Q Lace Liquid

Active Ingredient: Docusate sodium 10 mg (in each mL)

Purpose: Stool Softener

Uses

Warnings

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions


Adults and children over 12 years
50 to 200 mg (5-20 mL)
Children 12 to under 6 years
40 to 120 mg (4-12 mL)
Children 3 to under 6 years20 to 60 mg(2-6 mL)
children under 3 years
Ask a doctor
Higher doses are recommended for initial therapy. Dosage should be adjusted to individual response. The effect on stools is usually apparent 1 to 3 days after the first dose. This product must be given in a 6 to 8 oz. glass of milk or fruit juice or infant formula to prevent throat irritation

Other information
Shake well before use.
Store at room temperature. Protect from excessive heat.
Dispense in a tight container as described in official compendia.

Inactive ingredients

citric acid, D&C red no. 33, flavor, methylparaben, Poloxamer, propylene glycol, propylparaben, purified water, sodium citrate.

Manufactured for:

Qualitest Pharmaceuticals
130 Vintage Drive
Huntsville, AL 35811
USA

Container Label


DOC Q LACE 
docusate sodium   liquid
Product Information
Product TypeHUMAN OTC DRUGNDC Product Code (Source)0603-0746
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Docusate sodium (Docusate) Docusate sodium10 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
anhydrous citric acid 
D&C red no. 33 
methylparaben 
propylene glycol 
propylparaben 
sodium citrate 
water 
Poloxamer 407 
Product Characteristics
Color    Score    
ShapeSize
FlavorLEMON (Lemon Vanilla Flavor) Imprint Code
Contains    
Packaging
#NDCPackage DescriptionMultilevel Packaging
10603-0746-58473 mL In 1 BOTTLE, PLASTICNone

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33410/05/1990

Labeler - Qualitest Pharmaceuticals (011103059)
Registrant - Silarx Pharmaceuticals, Inc (161630033)
Revised: 12/2010Qualitest Pharmaceuticals